With clinical trial success, further deals & expansion, possible profit within the year. We could easily have a MC of $50-100mil 2018.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025